Showing results (161-170 of 697) with videos related to

Sort By:
Pageof 70
British Journal of Haematology|May 10, 2026
Predictors of renal response in AL amyloidosis following anti-plasma cell therapy: The impact of baseline serum free light chain levels and light chain isotypeMatthew J Rees, Binoy Yohannan, Susan Geyer, et al.
Blood Cancer Journal|November 17, 2018
Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myelomaPraful Ravi, Shaji K Kumar, Lindsey Roeker, et al.
Mayo Clinic Proceedings|May 6, 2015
Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin depositsGauri Bhutani, Samih H Nasr, Samar M Said, et al.
Blood Cancer Journal|July 18, 2026
Combination of daratumumab, ixazomib, and lenalidomide with or without dexamethasone for initial therapy of newly diagnosed myelomaShaji Kumar, Betsy Knopf, Erik Asmus, et al.
Cancer|June 29, 2019
Characteristics of long-term survivors with multiple myeloma: A National Cancer Data Base analysisRonan W Hsieh, Ronald S Go, Jithma P Abeykoon, et al.
American Journal of Hematology|March 11, 2015
Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin TAngela Dispenzieri, Morie A Gertz, Amy Saenger, et al.
American Journal of Hematology|February 4, 2020
Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosisSurbhi Sidana, Eli Muchtar, M Hasib Sidiqi, et al.
American Journal of Hematology|October 13, 2016
Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluationYi L Hwa, Qian Shi, Shaji K Kumar, et al.
Blood Cancer Journal|November 10, 2018
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myelomaM Hasib Sidiqi, Mohammed A Aljama, Irbaz Bin Riaz, et al.
Blood|June 25, 2014
Trends in survival of patients with primary plasma cell leukemia: a population-based analysisWilson I Gonsalves, S Vincent Rajkumar, Ronald S Go, et al.
Pageof 70